Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Janine M. Morsman
Observed names:
J Morsman,
J.M. Morsman,
Janine Morsman,
Morsman Jm
Institution:
Sanofi (United Kingdom)
Observed institutions:
University of Aberdeen,
Sanofi (United Kingdom),
Plymouth Hospital
OpenAlex ID:
A5011454862
Human CYP1B1 and Anticancer Agent Metabolism: Mechanism for Tumor-Specific Drug Inactivation?
2001
·
Bertrand Rochat
, Janine M. Morsman
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
219
Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase).
1996
·
B C Jones
, G Hawksworth
, et al.
·
Drug Metabolism and Disposition
·
82
Evaluation of dihydropyrimidine dehydrogenase activity in South‐west Asian, Kenyan and Ghanaian populations
2000
·
Janine M. Morsman
, Julieann Sludden
, et al.
·
British Journal of Clinical Pharmacology
·
30
PDF
Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
1999
·
F Caponigro
, A Avallone
, et al.
·
PubMed
·
21
Controlled release prostaglandin E2 pessaries
1990
·
W.R. Baravilala
, C. Baker
, et al.
·
The Lancet
·
5
Differentiation of HepG2 and Huh7 cells using dimethyl sulfoxide
2010
·
Catherine Anne Mowbray
, Alison Howard
, et al.
·
The FASEB Journal
·
2
Differentiation of secondary hepatocyte cell lines towards an in vivo hepatic phenotype
2009
·
CA Mowbray
, Janine M. Morsman
, et al.
·
Proceedings of The Physiological Society
Structure-activity relationship (SAR) for Cytochrome P4502C9.
1999
·
Morsman Jm
·
Europe PMC (PubMed Central)
Show more works
View as search
Works count:
8
Citation count:
359
H-index:
5
I10-index:
4
Year
Topic
Type